High Grade Endometrial Carcinoma
1 clinical trials · Condition
◉ Watch High Grade Endometrial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications (NCT05827614) | Boundless Bio, Inc. | 2023-03-24 |
Track High Grade Endometrial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.